Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT03279094
What this trial is testing

Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
City of Hope Medical Center 11
Testing effectiveness (Phase 2)Study completedNCT00003954
What this trial is testing

Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Fred Hutchinson Cancer Center 40
Early research (Phase 1)Ended earlyNCT04203017
What this trial is testing

Fecal Microbiota Transplantation After Autologous HSCT in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
St. Petersburg State Pavlov Medical University 20
Early research (Phase 1)Study completedNCT00990717
What this trial is testing

Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies

Who this might be right for
LeukemiaLymphomaMyeloma+1 more
University Health Network, Toronto 8
Not applicableStudy completedNCT00333190
What this trial is testing

CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation

Who this might be right for
Hematologic MalignancyAMLALL+4 more
Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)WithdrawnNCT04334174
What this trial is testing

Study of Brentuximab Vedotin as Therapy After Autologous Stem Cell Transplant in Cluster of Differentiation Antigen 30 (CD30) Positive Peripheral TCell Lymphomas

Who this might be right for
T Cell Lymphoma
University of Kansas Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT07362810
What this trial is testing

G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB)Hematopoetic Stem Cell TransplantationHemato-oncologic Patients
Fudan University 224
Not applicableStudy completedNCT03009708
What this trial is testing

Feasibility Study of Platelet Activation and Inflammatory Response of Platelets in Hematopoietic Stem Cell Allograft Patients Post-transplant: Spontaneously and After Stimulation by an CMV Antigen

Who this might be right for
Allograft
Institut de Cancérologie de la Loire 15
Testing effectiveness (Phase 2)Ended earlyNCT01343368
What this trial is testing

Preservation of Ovarian Function After Hematopoietic Cell Transplant

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaHodgkin Disease+2 more
Masonic Cancer Center, University of Minnesota 19
Not applicableStudy completedNCT00168168
What this trial is testing

ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159

Who this might be right for
Peripheral Stem Cell/Marrow Transplant
Alberta Health services 60
Not applicableEnrolling By InvitationNCT04503213
What this trial is testing

Assess CSF1R-related Leukoencephalopathy After Stem Cell Transplantation

Who this might be right for
CSF1R-related LeukoencephalopathyALSPPOLD+1 more
Mayo Clinic 20
Early research (Phase 1)Study completedNCT01092195
What this trial is testing

Gardasil Vaccination in Post Stem Cell Transplant Patients

Who this might be right for
Gardasil VaccineStem Cell TransplantImmunogenicity
National Heart, Lung, and Blood Institute (NHLBI) 64
Early research (Phase 1)Study completedNCT01318330
What this trial is testing

Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD)

Who this might be right for
Graft-vs-Host Disease
HomeoTherapy Co., Ltd 10
Not applicableStudy completedNCT03575767
What this trial is testing

Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT

Who this might be right for
Hematologic NeoplasmsHematopoietic Stem Cell TransplantationGraft Vs Host Disease+1 more
Affiliated Hospital to Academy of Military Medical Sciences 30
Not applicableUnknownNCT06075212
What this trial is testing

Immune Reconstitution After Allo-HSCT and Blinatumomab

Who this might be right for
Leukemia, Lymphoid
Sichuan University 20
Not applicableStudy completedNCT05349565
What this trial is testing

Effects of Muscle Energy Technique in Knee Osteoarthritis Patients

Who this might be right for
Knee Osteoarthritis
Riphah International University 26
Not applicableLooking for participantsNCT06208137
What this trial is testing

Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution.

Who this might be right for
Transplant-Related Disorder
Institute of Hematology & Blood Diseases Hospital, China 456
Testing effectiveness (Phase 2)Study completedNCT01252667
What this trial is testing

Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia
Fred Hutchinson Cancer Center 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT05393804
What this trial is testing

Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 24
Early research (Phase 1)Ended earlyNCT00943293
What this trial is testing

Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies

Who this might be right for
PreleukemiaMyeloproliferative DisordersLymphoma+2 more
University of Chicago 1
Next Page